Академический Документы
Профессиональный Документы
Культура Документы
Textbook Coloproctology A Practical Guide 1St Edition John Beynon Ebook All Chapter PDF
Textbook Coloproctology A Practical Guide 1St Edition John Beynon Ebook All Chapter PDF
https://textbookfull.com/product/a-practical-guide-to-optical-
microscopy-1st-edition-john-girkin-author/
https://textbookfull.com/product/ballistic-trauma-a-practical-
guide-4th-edition-john-breeze-et-al-eds/
https://textbookfull.com/product/mastering-physician-engagement-
a-practical-guide-to-achieving-shared-outcomes-1st-edition-john-
w-showalter-md-msis/
https://textbookfull.com/product/arthurian-magic-a-practical-
guide-to-the-wisdom-of-camelot-first-edition-john-caitlin-
mathews/
Practical NMR spectroscopy laboratory guide using
Bruker spectrometers 1st Edition Harwood John S.
https://textbookfull.com/product/practical-nmr-spectroscopy-
laboratory-guide-using-bruker-spectrometers-1st-edition-harwood-
john-s/
https://textbookfull.com/product/crisis-intervention-a-practical-
guide-1st-edition-alan-a-cavaiola/
https://textbookfull.com/product/integrated-modular-treatment-
for-borderline-personality-disorder-a-practical-guide-to-
combining-effective-treatment-methods-1st-edition-w-john-
livesley/
https://textbookfull.com/product/a-practical-guide-to-
construction-adjudication-1st-edition-pickavance/
https://textbookfull.com/product/psychotherapy-a-practical-
guide-1st-edition-jeffery-smith-auth/
John Beynon
Dean Anthony Harris
Mark Davies
Martyn Evans Editors
Coloproctology
A Practical Guide
123
Coloproctology
John Beynon • Dean Anthony Harris
Mark Davies • Martyn Evans
Editors
Coloproctology
A Practical Guide
Senior Editor
John Beynon
Department of Colorectal Surgery
Singleton Hospital
Swansea
United Kingdom
Editors
Dean Anthony Harris Martyn Evans
Department of Colorectal Surgery Department of Colorectal Surgery
Singleton Hospital Singleton Hospital
Swansea Swansea
United Kingdom United Kingdom
Mark Davies
Department of Colorectal Surgery
Singleton Hospital
Swansea
United Kingdom
v
vi Contents
xi
xii List of Contributors
Key Points
1.1 Introduction
Crohn’s disease (CD) is a chronic inflammatory condition of the bowel with between
3000 and 6000 new cases diagnosed each year in the UK and around 115,000 peo-
ple in the UK are living with CD. The diagnosis of CD represents a wide range of
S.O. Adegbola, BSc (Hons), MBBS, MRCS • K. Sahnan, BSc (Hons), MBBS, MRCS
P.J. Tozer, MBBS, FRCS (Eng), MD (res) • O. Faiz, MBBS, FRCS, MS
A. Hart, BM, BCh, FRCP, PhD (*)
St Mark’s Hospital, Watford Road, Harrow, Middlesex, HA1 3UJ, UK
e-mail: alisa.hart@nhs.net
1.2 Classification
Perianal Crohn’s disease can manifest in a variety of ways ranging from simple anal
skin tags to complex networks of fistulae and abscesses (see Fig. 1.1). There has
been no generally accepted method of documenting these, with resultant discrepan-
cies in the classification and inclusion of perianal lesions in different studies. The
first classification based on surgical pathology was published from Cardiff in 1978
1 Management of Perianal Crohn’s Disease in the Biologic Era 3
[15, 16]. Anal lesions in pCD were sub-divided into primary and secondary lesions
where primary lesions were considered to be part of Crohn’s disease and secondary
lesions arose from mechanical or infective complications of the primary lesions.
However, further experience by the author led to the Hughes classification of 1992
[16] with the inclusion of incidental perianal lesions of unrelated conditions coex-
isting with CD (e.g. haemorrhoids). Rarer entities, such as perianal fistulas originat-
ing from ileal (i.e. enterocutaneous) rather than anal disease and the complication of
malignancy in long-standing cases, are also covered. Uptake of these classifications
has been modest though, due to limited clinical applicability and relevance, particu-
larly when considering the effect on patient management [17]. This issue was high-
lighted by the American Gastroenterological Association (AGA) clinical practice
committee in 2003, when they published a technical review of pCD [18]. They
proposed a more empirical approach based on physical examination to identify the
spectrum of perianal disorders associated with CD as well as endoscopic examina-
tion to determine inflammatory status of the rectum.
In our review, we adopt a similarly empirical approach and describe lesions
according to anatomical location, i.e. skin lesions (e.g. anal skin tags) anal canal
disease (e.g. fissure, ulcers, stenosis/stricture), perianal abscess and fistula.
4 S.O. Adegbola et al.
Anal skin tags are a common finding in the context of pCD. Reported prevalence
varies between 24% and 75% [19–21] although these data are largely from tertiary
centres and therefore may represent a selection bias. Whether the skin tags are
symptomatic is also generally poorly reported in epidemiological studies. The pae-
diatric inflammatory bowel disease (IBD) collaborative group registry reported a
4% incidence of non-fistulising anal CD (including skin tags and fissure) at the time
of diagnosis [22]. The cumulative probability of perianal skin tags in the only popu-
lation study of its kind was 18.7% (95% CI, 13.9–23.3) at 10 years [9]. The same
study also indicated that 14–50% of skin tags may be symptomatic and that baseline
factors associated with time to first perianal skin tags in univariate analysis were
female gender, former cigarette smoker status relative to non-smokers and the pres-
ence of extra-intestinal manifestations [9].
Anal skin tags (ASTs) were initially classified (according to the Hughes/Cardiff
classification) along with anal ulcers with which they were thought to be associated.
However, the American Gastroenterology Association (AGA) more recently classi-
fied ASTs into two types [18]:
–– a large oedematous type which is often hard and cyanotic and typically arising
from a healed anal fissure, ulcer or haemorrhoid, (lymphoedema secondary to
lymphatic obstruction has also been postulated as a potential cause) and
–– “Elephant Ears” type, which is flat, soft/compressible, of varying size (but usu-
ally smaller than the above).
Anal fissures are common in Crohn’s disease with a prevalence of 10–29% [21,
25–31] reported. Cumulative probability in a population study of 310 incident cases
of Crohn’s disease was reported as 10.5% at 10 years [9].
Superficial fissures in non-IBD cases are usually found in the posterior midline
or less commonly the anterior midline, whereas CD fissures have been thought to
occur in more lateral positions [31, 32]. However, there have been several more
1 Management of Perianal Crohn’s Disease in the Biologic Era 5
recent studies which challenge this view and suggest that the majority of fissures in
Crohn’s disease are found in the anterior or posterior midline [31, 33, 34]. They are
often described as painless when associated with pCD [18], however, it is important
to note that painful fissures can and do occur in CD [31, 33] where they are also
often multiple in contrast to non-IBD fissures. Furthermore, they are closely related
to anal ulcerations, see Fig. 1.2 (with which they are sub-classified in the Hughes/
Cardiff classification) as well as other perianal Crohn’s conditions, e.g. skin tags
[16, 33].
Non-IBD anal fissures are thought to occur due to anal trauma in the form of the
passage of hard, bulky stool and persist due relative ischaemia influenced by high
anal tone. The aetiology of anal fissure in Crohn’s disease is thought to be related to
inflammation, and the treatment is also therefore different. In a retrospective study
[33], medical treatment including steroids, antibiotics or amino-salicylate healed
fissures in 46% of 52 patients after a median follow-up of 92 months. The exact
route (i.e. topical/systemic) or regimen was not specified. Factors predictive of suc-
cessful medical treatment included male gender, painless fissure, and acute fissure.
Infliximab has also been reported to be successful in both inducing healing and
long-term maintenance [35, 36]. In this retrospective study by Bouguen et al. com-
plete healing was observed in 53% (18/34) in the short term (i.e. follow up: 4–12
week). Long-term follow-up data revealed a healing rate of 70.6% (24/34) at median
follow-up duration of 175 weeks (range, 13–459) [36].
There are few published data on the efficacy of surgery for fissures in
pCD. Furthermore, little is known about the impact of proctitis on outcomes of fis-
sure surgery in pCD [31, 33]. The concern is that surgery will not improve the
patient’s symptoms and could actually make the situation worse. The septic compli-
cations as a consequence of surgery have necessitated later proctectomy [31, 37].
6 S.O. Adegbola et al.
Anal ulceration is less common than other pCD lesions. Siproudhis et al., reported
an incidence of 5% in a series of 101 CD patients with perianal sepsis referred to a
tertiary institution [38]. The most common symptom is pain, especially on defaeca-
tion [38]. Patients can also experience pruritus, discharge, and bleeding [23]. Ulcers
tend to extend deep to the dermis and can be large, oedematous and have irregular
edges [23]. They can be found in the anal canal, the lower rectum and in some cases
may extend to the surrounding peri-anal skin in aggressive disease [16].
Anal ulcers are often associated with distal rectal inflammation and can predis-
pose to other forms of pCD such as fistulae, abscess and anal stenosis. Cavitating
ulcers are often more symptomatic and more likely to evolve into fistulae [23].
In the case of deep cavitating ulcers the long term outcome is poor and nearly 50%
of patients progress to anal stenosis [39]. Studies on symptomatic pCD, including
patients with ulcers, have shown some benefit of topical treatments such as metronida-
zole (10%) ointment to improve symptoms [40]. Topical tacrolimus has been shown to
improve the depth of the ulcer but the studies are small and further, randomized evalua-
tion is needed [41, 42]. The evidence for systemic treatment is mostly from retrospective
series. A benefit was demonstrated in 63% of patients after three intravenous infusions
of infliximab at 2 months following the first infusion, assessed using a combination of
functional scores and proctological examination [43]. Bouguen et al., demonstrated
complete response in 40 out of 94 patients (43%) at induction and complete response in
72% after maintenance treatment for ulcers after a median follow up of 3 years [36].
Anal stenosis is an abnormal narrowing of the anal canal that can cause proximal
obstruction but can also lead to symptoms of discomfort and pain. Up to half of
Crohn’s anorectal stenoses are in the rectum, a third are in the anal canal and the
remainder are anorectal [44]. Patients often have other forms of pCD such as ulcers,
fissures and fistula. It is the inflammatory process which leads to fibrosis and even-
tually to circumferential stenosis. The prevalence of stenosis is between 9% and
22% and is more commonly found in patients with colonic than ileocolonic disease
[45], approximately 96% of cases have associated proctitis [23]. Fields and col-
leagues, found more manifestations of pCD in a cohort of 70 CD patients with ste-
nosis compared to controls: perirectal fistulae (61% vs. 34%), peri-rectal abscess
(50% vs. 17%) and anal skin tags (23% vs. 16%) [45].
One theory of anal stenosis is that it is the end result of a severe inflammatory
process and is a predictor of poorer outcomes, including proctectomy [44]. One
study demonstrated that patients with anal stenosis had a higher rate of temporary
diversion (OR 3.90, 95% CI 1.18–15.8, p = 0.03) and permanent stoma (OR 3.69,
95% CI 1.39–10.7, p = 0.01) on multivariate analysis [46].
1 Management of Perianal Crohn’s Disease in the Biologic Era 7
Stenosis in patients with Crohn’s disease tend to present later than in those
patients without Crohn’s disease in which constipation tends to be a feature. In
Crohn’s patients, stenosis tends to be associated with proctitis and looser stools,
therefore constipation tends to be less of a presenting feature. Instead the patients
typically present with other manifestations of perianal sepsis, such as fistulae which
lead to detection of the stricture [44, 47]. A digital rectal examination may be impos-
sible due to the degree of stenosis, but where possible the level and length of the
stenosis should be noted in reference to the dentate line [48].
Ideally patients should be assessed using a multi-disciplinary approach. Focused
histories on current and past medical treatments and perianal disease, as well as the
nature of the patient’s bowel motion (consistency and frequency) should be under-
taken. Following this an examination under anaesthesia with biopsies to exclude
malignancy should be performed. Imaging (usually MRI) is used to ascertain the
morphology (the anatomical location, the length and extent of stricture and any
associated perianal disease) of the stenosed segment.
Treatment can be determined in accordance with the severity of the presentation
and the anatomical nature of the stenosis. However, anatomical correlation with
symptomatology can be poor.
Stool softeners can be helpful in the short term, especially if the stool is firm.
In mild stenosis, if the patient is motivated and amenable, manual digitation
(with a single digit) or appropriately sized dilators can prevent deterioration of
the stenosis. Galandiuk and colleagues, found patients with anal stricture who
performed self-dilatation with Hegar dilators were less likely to require diversion
[46]. This is more useful in shorter strictures where it is easier for the patient to
undertake. Topical treatments with steroids or five ASAs or metronidazole have
been described [48].
An examination under anaesthesia (EUA) and dilatation with Hagar dilators is
usually warranted in mild-moderate stenosis even in cases of the severely scarred
Crohn’s anus [49]. Ideally gentle progressive dilatation up to 22–26 mm in diameter
can be used in adults [50]. A coaxial balloon technique can also be applied for dila-
tation [44]. Trauma as a consequence of over vigorous dilatation may lead to further
stenosis. Patients who self-dilate must be counselled appropriately and supported
by specialist nurses and regular clinic appointments as bleeding and sphincter dam-
age have been reported with dilatation [51].
Interposition flap procedures have been described in the absence of significant
rectal mucosal disease though some studies have shown CD has a negative impact
on healing in flap repairs [15, 52–54]. Anal stricture in association with perianal
sepsis is a poor prognostic feature and is likely to require faecal diversion [44].
Galandiuk et al. found in a study of 356 patients with CD, the presence of both an
anal stricture and colonic disease had a 30-fold increase in the likelihood of a per-
manent stoma compared to those patients with colonic disease without anal stricture
[46]. Proctectomy should be considered when medical and surgical therapies have
been exhausted.
8 S.O. Adegbola et al.
1.7 Abscess
Perianal abscesses are a common complication in Crohn’s disease and one study
found up to 62% of Crohn’s patients will develop at least one during the course of
the disease [30]. Two suggested aetiologies have been described including the cryp-
toglandular hypothesis [54] and Hughes’ theory that rectal inflammation leads to
ulcers which in turn evolve into fistulae [15]. More recent studies have also pro-
posed the role of genetics [5, 55–58] and an alteration in or unregulated response to
the normal GI microbiota [59–62] in perianal Crohn’s abscess/fistula.
An abscess may present acutely with pain in the perianal region as a local-
ized, erythematous swelling. Signs include a swollen tender lump with sur-
rounding erythema. Abscesses are classified anatomically in relation to the anal
sphincter (e.g. intersphincteric, superficial, suprasphincteric etc). In a prospec-
tive series of 126 patients with pCD, just under half (48%) had at least one
perianal abscess [63].
Clinical examination often reveals the location of the abscess, but in more com-
plex presentations EUA is a useful diagnostic adjunct with a specificity of 91% [13,
64] Certain anatomical locations, such as intersphincteric [65], are more difficult to
assess clinically and imaging such as MRI or endoanal ultrasound [66] if tolerated,
in combination with an EUA may be needed to identify the abscess. Abscesses
appear as areas of high signal intensity in T2 weighted MRI scans and may be asso-
ciated with a rim of inflammatory tissue [67].
Antibiotic therapy is required if there are signs of systemic sepsis and can be
used in combination with the patient’s normal immunomodulators [68–70]. A com-
mon cause of recurrence of the abscess is undrained sepsis, so patients will usually
undergo incision and drainage.
An abscess is part of the natural history of the untreated anal fistula and
although they may occur separately, both are more common in Crohn’s disease
than in the general population—an underlying fistula should be sought when an
abscess is found. Makowiec et al., found that 73% of abscesses were associated
with an ischiorectal fistula and 50% with a trans-sphincteric fistula [63]. In the
acute setting, the abscess should be drained and if a fistula is identified, seton
suture placement is advised. However, caution should be exercised in the acute
setting, as probing the acutely inflamed ano-rectum in search of a fistula, may
cause iatrogenic injury.
1.8 Fistula
Anal fistulae occur in a third of all Crohn’s disease patients [71]. They denote a
distinct and aggressive phenotype [12], with a higher risk of a severe and disabling
disease course, relapse and the need for repeated operations. They cause pain and
discharge and result in a reduced quality of life [72]. In a population study, Schwartz
et al. found the cumulative risk of at least one perianal fistula after 1 year was 12%,
after 10 years was 21%, and after 20 years was 26% [13].
1 Management of Perianal Crohn’s Disease in the Biologic Era 9
Crohn’s anal fistulae were first described in 1934 [73] and it is known that they
can precede luminal disease [7]. Anal fistulae are the initial manifestation and the
presenting complaint in 10% of patients with Crohn’s disease [74]. Patients diag-
nosed before the age of 40 are at an increased risk of a penetrating phenotype,
including anal fistula [75]. Anal fistulae are more common in men, non-Caucasians
and Sephardic (as opposed to Ashkenazi) Jews [ 11, 12, 75, 76]. Patients with
colonic disease but specifically those who have active rectal disease are at greatest
risk of developing fistulae [77].
A number of classification systems exist for anal fistulae including Hanley’s
[78], Parks’ [79] and the American Gastroenterological Association (AGA) [18]
classification which describes fistulae as either simple or complex. Simple fistu-
lae have one external opening and are low (below the dentate line; superficial,
inter- or trans-sphincteric). Complex fistulae may have more than one external
opening, be high (above the dentate line; inter-, trans-, supra-, or extra-sphinc-
teric) or have extensions (a term denoting abscess/secondary tracts). Patients
with Crohn’s disease can present with either, but complex fistulae are more com-
mon in Crohn’s than non-Crohn’s patients. They have a tendency to recur and
often patients require multiple operations (see Fig. 1.1) [80]. With repeated sur-
gery and episodes of sepsis the fistulae become harder to assess both clinically
and radiologically due to an increase in scar tissue and distortion of the surround-
ing anatomy [81]. Assessment includes a focused history, examination including
procto-sigmoidoscopy. MRI is the gold standard for imaging anal fistula and has
been shown to be superior to examination under anesthesia [82] and endoanal
ultrasound [83]. A technical review by the American Gastrointestinal Association
[18] found a diagnostic accuracy of 76–100% in complex Crohn’s fistula [64,
84–90]. However, the location of the internal opening can be difficult to ascertain
on MRI [90]. Schwartz et al., demonstrated in 32 patients with perianal Crohn’s
fistula that diagnostic accuracy could be improved if two modalities (MRI, endo-
anal ultrasound, EUA) were used in combination [87]. Establishing the presence
or absence of proctitis is fundamental and influences both treatment and progno-
sis. Procto-sigmoidoscopy or formal endoscopy should be performed to deter-
mine this [67].
Established treatment principles involve draining the sepsis and aggressively
managing proctitis whilst treating the fistula medically, usually with a combination
of antibiotics, thiopurines and anti-TNF therapies. Clinical response to treatment is
defined as a 50% decrease in the number of external openings and/or a lack of dis-
charge from these openings over two consecutive clinic visits [91]. Clinical remis-
sion or ‘healing’ is the complete cessation of drainage despite gentle finger pressure
or the healing of all external openings. This subjective, clinical drainage assessment
has been criticised for failing to appreciate the natural history of anal fistulae and
failing to assess residual tracts which have been radiologically shown to heal a
median of a year after clinical ‘healing’ by Tozer et al. [82].
Previous attempts to standardize radiological response, such as the [92] van
Assche system have been criticised due to insensitivity to change in the long term
[93] and weak correlation with PDAI (r = 0.371, p = 0.036) [92]. Currently, there is
10 S.O. Adegbola et al.
The combination of anti-TNF therapy and seton insertion has been assessed
recently in a multicentre observational study [105]. Both utilization of infliximab
prior to surgery [106, 107] and seton insertion prior to infliximab have demonstrated
benefit [108].
The search for clinical factors which can predict response to therapy and relapse
rate is a focus for current research [109]. The role of antibodies and trough levels of
the anti-TNF agents have also been explored and indeed both may guide therapy
[110, 111].
Continuing with the first anti-TNF agent is usually recommended unless there is
a loss in response. Several studies have shown some benefit of changing biological
agents after a loss of response to anti-TNF therapy. The CHARM study showed
benefits in both the anti-TNF naïve patients and those who had switched to adalim-
umab. In this study, patients who had received infliximab or any TNF antagonist
other than adalimumab, greater than 12 weeks before screening, could be enrolled.
This was provided they did not exhibit initial nonresponse to the agent (i.e. no clini-
cal response to first injection as judged by the investigator). Fistula response was
found in 41% of patients at 56 weeks [112]. Of all those patients who had fistula
response (including those in the placebo group), 90% had maintained response fol-
lowing 1 year of open-label adalimumab therapy, for at least an additional year
[113, 114]. Similarly, the CHOICE trial found complete fistula closure in 34/88
(39%) treated with adalimumab after loss of response to infliximab [115].
The role of adalimumab following lack of response to infliximab has been con-
sidered in several studies. Notably, the GAIN study found no difference between
adalimumab and placebo as a second line agent [114].
An other anti-TNF therapy used thus far in pCD is Certolizumab Pegol. This was
compared against placebo and assessed at 26 weeks in the PRECISE 1 and 2 trials.
Of the 55 patients with perianal fistula the closure rate was superior with
Certolizumab compared to placebo (36% vs. 17%, p = 0.038). However, the differ-
ence was not statistically significant (54% vs. 43%, p = 0.069) for the protocol defi-
nition of fistula closure (≥50% closure at two consecutive post-baseline visits
≥3 weeks apart) [116, 117]. Trials are ongoing with newer monoclonal agents such
as Vedolizumab which may prove to be a viable alternative.
The role of surgery is predominantly to assess and drain the fistula complex prior
to medical management. Due to the risks of impairment of continence, recurrence
and poor wound healing, fistulotomy is rarely (if ever) appropriate in Crohn’s dis-
ease. Sphincter preserving treatments may be considered and data on drainage
procedures (long term loose seton), disconnection procedures (advancement flaps,
the LIFT procedure), infill procedures (glues, plugs) and ablative procedures
(VAAFT, FiLaC™), whilst mostly limited to case series, have shown feasibility in
Crohn’s disease.
In the context of rectal inflammation and a complex fistula, a long term loose
seton in combination with medical therapies can be effective [118, 119]. Cutting
setons are less widely used and it is argued that they cause pain and sphincter
injury [50]. A long-term loose seton is an acceptable management strategy in
some patients and may only need to be changed in the case of persistent
12 S.O. Adegbola et al.
inflammation (which suggests they are not fulfilling the function of a conduit for
suppuration and that further drainage may be needed), snapping or calcification.
More commonly the loose seton is placed to ensure full drainage of all perianal
sepsis prior to anti-TNF therapy. Traditionally and empirically seton removal has
been after the second infliximab infusion however more recent evidence suggests
decreased fistula recurrence rates when setons are left in place longer [120, 121].
There is no consensus as to the optimum time to remove the seton and the ongoing
PISA trial attempts to address this issue [122]. Setons may be used as a bridge
between draining the initial sepsis and optimizing the patient medically before
definitive surgical treatment.
‘Infill strategies’ such as glues and plugs have been employed with varying suc-
cess. The closure rate was 57% at 23.4 months in one study of 14 patients [123]. A
systematic review found a 55% fistula closure rate in a pooled analysis of 42 patients
[124]. The initial success for infill strategies has not been replicable in other centres
and limited long-term data are available in pCD [124]. There are however potential
uses for these materials as scaffolds for newer therapies such as stem cells and local
pharmaceuticals. Indeed, a phase II multicentre study of complex fistula (14 patients
out of 49 had pCD), compared glue vs. glue and expanded adipose-derived stem
cells (ASCs) and reported healing in 16% vs. 71% respectively, with a one-year
recurrence rate of 17.6% in the ASCs group [125].
Endorectal advancement flaps (ERAF) for anorectal and rectovaginal fistula
(RVF) have been used in Crohn’s disease with variable success. The surrounding
mucosa in the rectum must be healthy and creating a tension free anastomosis is key
[48]. Patients with perineal descent and/or internal intussusception are often better
suited to advancement flaps and surgeons may choose between mucosal, partial or
full thickness flaps. In a series of 36 Crohn’s fistulae, there was an 11% primary
failure rate and recurrence rate of 31% [126]. Solanti et al., performed a review of
the literature in which ten studies featured pCD with a 64% success rate and a 9.4%
incontinence rate [127] but multiple attempts at advancement flap were permitted.
A retrospective review from the Cleveland clinic identified 28 patients with pCD
and a higher recurrence rate was found compared to idiopathics (57.1% vs. 33.3%,
p < 0.04).
‘Ligation of the intersphincteric tract’ (LIFT) is a procedure used to treat trans-
sphincteric fistula. Many of the earlier studies excluded pCD however Gingold
et al., found 8 of 12 patients (67%) had LIFT site healing at 12 months [128]. In
patients without perineal descent it is an alternative to an advancement flap.
Complexity in the intersphincteric space and high fistula (difficult the surgical
access) are relative contraindications.
Novel treatments such as ‘Fistula tract laser closure’ (FiLaC™) and ‘Video
assisted anal fistula treatment’ (VAAFT) have shown some promising results in
cryptoglandular fistula but prospective trials in pCD are needed.
Intra-fistula injection of stem cells has been shown to be safe and a promising
area of research and has shown benefit in previously refractory complex fistula. De
la Portilla et al. performed an open-label, single-arm clinical trial in six Spanish
hospitals of 24 patients with pCD. At 24 weeks, 56.3% of patients achieved
1 Management of Perianal Crohn’s Disease in the Biologic Era 13
complete closure of the tract, with 30% achieving closure of all existing tracts;
defined clinically and radiologically as the absence of collections [129]. A Phase II
trial in Korea reported complete fistula healing (defined clinically) in 27/33 patients
(82%) at 8 weeks [130] and the same group have recently reported their 2 year out-
comes in which in modified per protocol analysis 75% had complete healing at
2 years defining clinically [131]. A longer follow up was found by Ciccocioppo
et al., who found a fistula free survival of 88% at 1 year, 50% at 2 years, and 37% at
4 years [132].
Faecal diversion can be a useful adjunct to complex pCD operations either in the
form of de-functioning colostomy or an ileostomy. A recent meta-analysis of 16
cohort studies (556 patients) found that 63.8% (95% CI: 54.1–72.5) of patients had
early clinical response after faecal diversion for refractory pCD. Whilst most often
the decision to de-function is regarded as temporary, the same study reported that
restoration of bowel continuity was only attempted in 34.5% (95% CI: 27.0–42.8)
of patients, and was successful (without relapse of symptoms or need for additional
surgery) in only 17% of patients [133]. The authors concluded that 42% of patients
undergoing restoration of bowel continuity go on to require proctectomy due to
relapse of symptoms.
In severe and refractory pCD, proctectomy can be considered. A combination of
immunosuppressive medications and chronic disease often mean the rates of poor
perineal wound healing are high. Yamamoto and colleagues found a persistent peri-
neal sinus in 33 out of 145 patients (28%) after proctocolectomy for Crohn’s disease
[134]. Other post-operative complications include recurrent sepsis, fluid collections
in the pelvic ‘dead space’ created and iatrogenic damage to pelvic nerves.
Proctectomy is often seen as a failure of management but in a few patients with very
severe perianal disease and/or proctitis, it may be a life changing intervention.
Careful discussion and counselling are crucial.
The overall aim of surgery in Crohn’s fistula is to provide high rates of closure
without significant impairment of continence whether by definitive surgical inter-
vention or, more commonly, by preparing a fistula tract for medical treatment [135].
However, despite advances in diagnosis, medications and surgical techniques, sur-
gery for complex pCD remains challenging [106, 136–139]. Recurrence and reop-
eration rates are high and proctectomy may ultimately be required in 10–18% of
cases [30, 118, 119, 140]. Complex fistulous disease may never be cured and for
some patients a palliative approach is currently the only option.
Rectovaginal or anovaginal fistulae (RVF) can occur in 10% of women with Crohn’s
disease and are classed as complex anal fistulae [141]. The majority occur in the
middle of the rectovaginal septum and are secondary to an anterior rectal ulcer
which erodes into the vagina [48]. RVF which are higher, associated with active
rectal disease or originating from a Bartholin’s abscess are associated with worse
symptoms and prognosis [77, 141–143].
14 S.O. Adegbola et al.
Symptoms include intermittent vaginal flatus, discharge [144] and, rarely, faecal
incontinence [48]. Examination under anaesthesia, proctoscopy and vaginoscopy
can be used in conjunction with contrast enemas or methylene blue infusion per
vaginal tampon to identify the tract. MRI may miss the fistula but provides informa-
tion about inflammatory changes, ongoing sepsis and may delineate fistula
morphology.
Management of RVF is dependent on anatomical location, complexity and
whether there is active inflammation in the rectum. A multidisciplinary team should
determine management options and reference must be made to severity of luminal
as well as perianal disease, the presence of localized sepsis, sphincter function
(through anorectal physiology studies) and treatment goals of the patient. Patients
should be appropriately counselled that there is often no ‘panacea’ treatment and the
risks of sphincter injury and recurrence should be explained.
The aim of the immediate treatment is to control proctitis and drain any underly-
ing sepsis. Surgical management is the mainstay but medical adjuncts are often used
to alleviate active inflammatory processes and control pre/post-operative bowel habit
[145]. The ACCENT II trial, included 25 patients with Crohn’s RVF who had inflix-
imab infusions. Following infusions at induction, 2 and 6 weeks 44% of fistulas were
closed at 14 weeks [146]. Infliximab has been shown to reduce hospitalisation and
the number of operations in fistulizing disease including a subgroup of RVF patients,
but it is less likely to be curative in RVF than perianal fistulae [18, 102].
Surgical options are indicated when there is endoscopic evidence of healed rec-
tosigmoid mucosa [18]. There is a lack of high quality data on the subject and the
options are varied including fistulotomy (rarely) if very superficial, trans-anal/vagi-
nal advancement flaps, Martius flaps [147], gracilis interposition and direct repair
with sphincter repair [148].
Mucosal advancement flaps have been found to have highly variable rates of suc-
cess ranging from 28% to 92% [126, 149, 150]. Makoweic et al., found that the recur-
rence rates at 2-year follow up were higher following advancement flaps for Crohn’s
RVF compared to anal fistulae (70%; 25%) [126]. In cases where proctitis cannot be
managed medically, options for treatment include anocutaneous flaps [151, 152] or
protectomy [141]. Full sleeve/Soave-type advancements have been described in the
presence of anal stenosis or in cases where the fistula has occurred at the site of an
anastomosis [153, 154]. As the failure rate of all surgical options is high, diverting
stoma should be considered. However, with long-term closure rates of 50%, patients
should be counselled appropriately, particularly where their symptoms are minimal.
1.10 Pregnancy
A recent retrospective review of all deliveries from 1998–2009 found patients with
pCD were more likely to have a caesarean section compared to those patients with
non-CD perianal disease (83.1% vs. 38.9%, p < 0.001). Multivariate analysis was
performed to identify independent risk factors of fourth degree lacerations. Crohn’s
disease alone was not a risk factor (OR 1.18; 95% CI, 0.8–1.8, p 0.4), perianal
1 Management of Perianal Crohn’s Disease in the Biologic Era 15
disease was (OR, 10.9; 95% CI, 8.3–4.1; p < 0.001) but a distinction between pCD
and non-CD perianal disease was not made [155]. The European Crohn’s and Colitis
Organisation (ECCO) guidelines recommend normal vaginal delivery as safe for all
patients except those with active perianal disease, but to avoid episiotomy where
possible [155, 156].
Epidemiologic data about anal cancer in patients with CD are scarce because the
majority of available articles are case reports or small case series [25]. It has previ-
ously been reported that the incidence of anal cancer is higher in patients with
Crohn’s disease [24]. Frisch and colleagues [26] sought to address this question
using a population-based estimate of the incidence of anal SCC in patients with
inflammatory bowel disease (IBD). Anal cancer was studied in 9602 patients with
Crohn’s disease or ulcerative colitis. They were followed for up to 18 years with
99,229 person years of observation. Two cases occurred vs. 1.3 expected
(Standardized Incidence Ratio—SIR 1.6 (95% CI 0.2–5.7)). The conclusion was
that although this may be a type 2 error and an association is present but not detected,
anal squamous cell carcinoma remains rare in patients with IBD.
Nevertheless, the association between complicated perianal Crohn’s disease and
cancer in the rectum and anus has also been reported by others [25, 27, 28]. Anal
cancer has been described in patients with longstanding anorectal fistulae in the
absence of Crohn’s disease and it is possible that chronic inflammation is more
important in the carcinogenesis than the presence of Crohn’s disease itself. The rar-
ity of anal SCC in Crohn’s disease makes accurate assessment of incidence and
prediction of risk difficult.
The diagnosis of anal cancer has often been delayed because of the non-specific
symptoms (similar to those in the patient with pre-existing pCD), unawareness of
the cancer risk or confusion between cancer and a benign stricture. Connell et al.
[28] reported their experience regarding the presence of lower gastrointestinal
malignancy in 15 of 1240 patients with CD seen at St Mark’s Hospital, UK, between
1940 and 1992. A total of five patients had anal cancer (all squamous cell carcino-
mas) and all five had chronic disease affecting the anorectal region (mean duration
18 years). Two patients had fistulae affecting the anus and rectum, one had a chronic
anorectal stricture, one a persistent perianal abscess, and one had a ‘grossly enlarged
skin tag’. Known risk factors associated with anal SCC such as HIV and infection
with HPV subtypes were not described in this retrospective study [28].
Many patients with anal lesions have few symptoms despite grossly distorted
perianal anatomy. Thus the diagnosis is clinched on the basis of heightened suspi-
cion and the possibility of malignancy should always be considered when examin-
ing chronic pCD of any type but in particular non-healing fistulae or ulcers.
Curettage or biopsy of the fistulous tract and histology of the biopsy material should
be performed when suspicion is raised either by chronicity, examination findings or
a change in symptoms.
16 S.O. Adegbola et al.
Anal SCC in Crohn’s disease should be managed in the same was as that in non-
IBD patients with the corresponding stage disease [27] and the expert consensus of
the AGA recommends that standard oncologic surgical principles and procedures
should be followed. The prognosis, however, tends to be poor due to the advanced
stage of the cancer and were excisional surgery required, the risk of poor perineal
wound healing remains high.
There are a number of questionnaires that are used in Crohn’s disease to determine
a patient’s quality of life. However, these can under-estimate the degree of morbid-
ity or impairment in quality of life specific to perianal disease. Such scoring tools
are therefore of limited use in assessing clinical progress/response to treatment in
pCD [18]. The Cardiff classification described in 1978 by Hughes [15] assigned a
score of 0–2 for each manifestation of perianal Crohn disease: ulceration, fistula,
and stricture, and also classified fistula location with respect to the dentate line. A
later modification added a score for proximal intestinal Crohn disease [16].
In 1995, Irvine proposed the Perianal Disease Activity Index (PDAI) [94]. This
sought to address the deficiencies of existing activity indices in recognising the peri-
anal complications of CD [18, 157]. The score was designed to improve the estima-
tion of pCD severity, both in clinical practice and in the context of clinical trials. The
PDAI focuses on five areas which assess quality of life (restriction of sexual activity,
pain/restriction of activities) as well as disease severity (type of perianal disease,
fistula discharge and degree of induration). In the study validation, there was good
correlation between the score and patient global assessment [94, 158].
A more recent scoring system proposed by Pikarsky et al. [157] is useful in
attempting to predict the outcome following surgical intervention in patients with
perianal Crohn’s disease. The index consists of six items that are ascertained during
history taking and physical examination, i.e. abscess, fistula, fissure and/or ulcer,
stenosis, incontinence. Each feature was rated on a point scale according to severity
and complexity. A score of zero indicates the absence of that feature. Uniformly, a
score of 1 represented de novo acute disease; 2, chronic disease; and 3, recurrent
disease [157]. An incontinence score of 1–6 was graded as 1 point, 7–14 as 3 points,
and more than 14 as 5 points using an incontinence score described by Jorge and
Wexner [159]. The scoring system has correlated well with short-term outcomes of
surgical intervention [158]. However, despite their ability to document the severity
of symptoms objectively, none of the above classification systems has gained wide-
spread acceptance owing to their lack of impact on clinical decision-making.
However, despite their ability to document the severity of symptoms objectively,
none of the above classification systems has gained widespread acceptance owing
to their lack of impact on clinical decision-making [91, 160].
The most widely used instrument for assessing treatment outcomes in clinical
trials is the Fistula Drainage Assessment [161], described above. It was introduced
as the primary end point in the trial of Infliximab for the ACCENT II trial. In this
1 Management of Perianal Crohn’s Disease in the Biologic Era 17
assessment tool, fistulas are classified as open (i.e. purulent material is expelled
with gentle pressure) or closed. A fistula has to remain closed for two consecutive
visits (at least 4 weeks apart) to be considered closed. If half of all external openings
are closed the patient has responded. If they are all closed they are in remission, at
least for that 4-week period. There are limitations of the Fistula Drainage Assessment
tool, as it does not consider changes in anal pain, which is an important marker of
treatment response.
The clinical course and overall prognosis of pCD largely depends on the clinical
picture (as discussed under the various headings), the location of disease and the
presence of proctitis. The natural history is however, difficult to predict, due to het-
erogeneous terminology in the literature. In general, skin tags and fissures are asso-
ciated with a more benign course, whereas complex anal fistulas, deep cavitating
ulcers and dense anorectal strictures tend to carry a poor prognosis. In general,
perianal disease in the absence of rectal inflammation has a better outlook than dis-
ease associated with rectal inflammation.
The lower threshold for the use of immunosuppressants and particularly anti-
TNF agents has improved outcomes of complex fistulising pCD. Short-term
improvements are seen in over 50% of patients and this maintenance can be seen
in up to a third of patients at 1 year. These medical treatments often have to be
used in conjunction with prompt drainage of sepsis and preservation of anatomy
to offer the best outcomes [162]. As well as drainage, surgery includes bridging
treatments (seton insertion, temporary faecal diversion) and definitive fistula
surgery.
A proportion of patients go on to have multiple attempts at controlling symptom-
atic disease. Despite these multiple therapeutic interventions, some patients remain
refractory to treatment and will require ‘temporary’ faecal diversion or eventual
proctectomy [133]. Diversion is usually in the form of a loop ileostomy or colos-
tomy and is intended to control the inflammatory process and optimise the patient’s
nutritional and general status prior to attempting definitive surgical treatment. A
quarter of patients require re-diversion after restoration of bowel continuity and just
under half of all patients requiring temporary diversion go on to eventual proctec-
tomy [133]. Interestingly, the use of anti-TNF therapy has not had a significant
impact on these rates. The absence of proctitis is the only significant factor associ-
ated with restoration of bowel continuity [163–165].
Conclusion
Each aspect of perianal Crohn’s disease is nuanced in its own way, with options
for management (see Fig. 1.3) which depend on the nature of the pCD and on the
patient, their symptoms and their burden of disease elsewhere, particularly in the
rectum. A multidisciplinary approach involving gastroenterologists, surgeons,
radiologists, IBD nurses and dieticians and an awareness of pCD, its forms and
Another random document with
no related content on Scribd:
“Study your spelling, Charlie.”
“Charlie, come up here and stand by my desk.”
And so throughout the year, Miss Marlowe ignored the facts that
ought to have led to a reformation of this little boy’s habits.
CONSTRUCTIVE TREATMENT
When a child shows he has not been given careful teaching relative
to sex hygiene, go to his mother and advise her to take the child to a
physician. Explain the physical as well as the moral and mental help
it may be to the child to have one of two very slight operations
performed, after which, with proper diet and bathing, the boy may
easily forget his wrong habits.
COMMENTS
Miss Vane saw a note fall upon Mary Pratt’s desk. She said,
“Mary, bring that note to me.”
The child, she knew had not yet read the note. Greatly
embarrassed, Mary looked questioningly at Clyde Mitchel before
starting toward Miss Vane.
Contrary to the courtesy which teachers Improper Notes
admonish pupils to show, Miss Vane stood
up, opened the note and perused it in the presence of the school.
While she was looking at the note, Clyde Mitchel buried his scarlet
face in his book.
“You wrote this note, didn’t you, Clyde?” asked Miss Vane.
Clyde only nodded “Yes,” and burrowed even deeper into his book.
“This is a shameful note,” said Miss Vane. “It contains words that
no child should ever write or speak. You may stay after school,
Clyde.”
The boys waited at the second corner from the school house for
Clyde after school.
In about ten minutes Clyde came running toward them.
“What did she do, Clyde?” they asked.
“Aw, nothing; she just preached a little and gave me a few licks
that wouldn’t hurt a baby.”
“What was in the note, anyway?”
He told them exactly what was in the note, and a loud “Hurray!”
went up from the group of listeners. The subject of conversation
among these boys as they went on down the street was as full of
unclean words and suggestions as the worst boys in the group could
think up.
CONSTRUCTIVE TREATMENT
If you can not deal with sex subjects privately, with pupils in the
lower grades, do not deal with them at all. Miss Vane made a mistake
in reading or referring to the note in the presence of others. In her
efforts to suppress such foul communications she occasioned a talk
upon the unnamable topics by all of her own room and many in other
rooms as well.
COMMENTS
CONSTRUCTIVE TREATMENT
Miss Terman should have drawn Pearl into the games of the other
girls early in the year. She should have said to the leader among the
girls, in private. “You have it in your hands to make a classmate
happy or miserable. You, yourself, will enjoy school better if no girl is
made sad and lonely. I know that the other girls will follow your lead
and, therefore, I desire that you invite Pearl Goodwin into your
school games and give her an opportunity to know and like good
company.”
COMMENTS
CONSTRUCTIVE TREATMENT
COMMENTS
Miss Fanson was a high school teacher who was justly admired by
the girls under her care. She had talked to the girls about the
deference and homage which they should show to their parents in
social matters. Alice Grant believed that Miss Fanson was exactly
right, hence was willing to act upon her teacher’s advice.
Since she had entered high school, boys had suddenly become very
interesting to Alice. She blushed one afternoon as she plucked up her
courage to reveal certain developments to her mother.
“Mother, the Freshmen are going to give a party, and a boy in my
German class has asked me to go. May I?” Her voice affected
indifference.
But Mrs. Grant knew her young daughter Retaining
and saw through that coolness. Her Alice Control
was excited and flushed and happy over a boy! And she stared
blankly for a moment as the realization forced its way. Then a
tempestuous refusal from a heart that resented her little girl’s
growing up sprang swiftly to her lips, but she kept back the words. It
did, indeed, hurt to have Alice begin to be a young lady, but could
even she, the most adoring of mothers, restrain time and the youth
that was blossoming in her child?
“I’ll have to think it over, Alice. I’ll tell you in the morning.”
And Alice went to her studying, confident that, whatever her
mother decided, she would be just and allow only big reasons to
weigh with her.
Mrs. Grant thought it over and that night talked it over with her
husband.
“She’s absurdly young—only fifteen,” he objected.
“Yes, but absurdly natural, too, and strong in her desires. I fear, if I
refuse, it may only surround boys with a mysterious glamour for her,
and she might then be tempted to associate with them in spite of me,
and any secrecy or deceit just now is dangerous. And you know our
Alice is growing pretty.”
Mr. Grant regretted and bemoaned the loss of his little girl, but
agreed. “But who is this boy?” he demanded. “Do you know him?”
“No. But I’m going to know all her friends from now on.”
And next morning, when Alice, pink-cheeked and eager-eyed,
sought her mother’s decision, she welcomed the “Yes” with a little
squeal of delight.
“But I’ve been thinking, Alice,” her mother added, “that I’d like to
know the boys and girls you’re going with. Wouldn’t you like to ask
some of them over here some evening before the party?”
“Would I? Well, rather! Mother, you’re a dear.”
“And what about a dress. I suppose you’d like a new one?” Further
question was stifled by an enthusiastic hug.
So they talked of the party and the dress, and then it was not far to
“the boys” and Alice’s new feeling for them. And Mrs. Grant felt that
the sweet intimacy she was entering with this new daughter more
than compensated for the loss of the little girl, who had suddenly
become a young woman.
When Alice returned from the party her mother showed interest in
each detail that her daughter related. She remarked: “You must have
had loads of fun—what did you have to eat? What did you especially
like in the conduct of your classmates?” It is while such concrete
subjects are being discussed that much guidance can be given the
daughter in her formation of opinions as to what is proper or
improper conduct. A teacher who brings about such intimacy as this
incident illustrates has done much for both mother and daughter.
ILLUSTRATION 2 (HIGH SCHOOL)
CONSTRUCTIVE TREATMENT
COMMENTS
The amative impulses of youth are not vicious, but need direction
and control. Self-control, above all else, is to be taught, and the
teaching must often be reinforced by wise, friendly restraint. Frank
friendships are to be encouraged; sickly, silly sentimentality laughed
out of court. If a teacher, instead of standing ready to give this help
and guidance when it is needed, encourages a sentimental devotion,
as Miss Kingsley did, the most fundamental safeguard of youth is
sacrificed—the ideal of controlled emotion, of a conscious saving of a
sacred experience for the future. A large range of interests, a healthy
balance of activities, and a wholesome unconsciousness of self, tend
to keep young people simple and child-like in their emotional lives.
Above all, no teacher has any business to give the impression that he
alone appreciates youth and its promise, or to make his relations
with impressionable boys and girls unduly personal.
Mr. Bradley was principal for two years of the Newcastle school.
He revealed his characteristics as a teacher so fully that we find in
him an example of the type not to be recommended and yet one that
is very instructive for students of school discipline.
In stature he was slightly below medium height. He came from
rural ancestry and was fairly well equipped as to physique. He had
black hair and eyes, somewhat mobile features and a wandering
gaze. His movements could hardly be called quick, but they were
prompt and without distinct mannerisms.
He had a most gracious manner when meeting people on the street
or in their homes. He spoke kindly to everyone and had the
reputation among the townspeople of being a royal, good fellow.
Even his pupils could not deny that he treated them very courteously
and jovially outside of school hours.
Despite all this he used essentially the method of the hen-pecking
incompetent when handling disciplinary matters in school. The
moment he entered the school precincts he was a different man. His
countenance then betrayed the sternness of the schoolmaster who
dwelt within and apart from the polite gentleman he seemed to be
when outside the school-room. His eyebrows gathered and his
muscles reverberated with the sense of authority that flooded his
whole nature.
His eye was on the lookout for misdemeanors and if a pupil made a
misstep in the realm where Mr. Bradley thought he had jurisdiction,
that harsh, strident voice, with but the slightest trace of fellow-
feeling, spoke the word of correction or announced an impending
penalty.
In the school-room it was his delight to slip up behind an offender
and pluck him by the ear as a reminder of duty. Being the only
instructor who indulged in this practice it soon came to be one of the
most odious signals of his presence in the room. When absorbed in
his subject he made instruction interesting; his pupils could not fail
to learn if they did not venture to vary the program by misconduct.
However, their recollection of his general attitude toward them, the
ease with which they could upset his plans by introducing a few
school pranks, the certainty that he would lose his temper on slight
provocation, always hung as a barrage screen between them and
undivided concentration on the subject-matter of their lessons.
Mr. Bradley made it a practice to watch for accumulating offenses.
He felt incompetent to handle minor evils, but attempted to squelch
a wayward pupil by reciting a list of grievances and applying
penalties for the same. He had a good memory for facts of this sort.
He could shake his finger in the face of a boy or girl and say, “Didn’t
you pull Esther’s hair yesterday ... trip up Jimmie on the way to class
in geometry and purposely spill the crayons when you were at the
board? Now, I have had enough of this. I want to know what you are
going to do about it.”
This gentleman could not catch the drift of things. Early in his first
year Mr. Bradley’s attention rested upon Ted. Ted was a short,
heavy-set chap of some fourteen years, incapable of any
revolutionary propensities, but able to interest himself with a variety
of aggravating tricks. His pranks were individually almost too small
to command severe penalties, but they were too annoying to escape
the principal’s eye.
Unfortunately, Mr. Bradley hit upon the lash as a cure for Ted.
Selecting a more pronounced misdemeanor as an opportunity for
settling accounts with the troublesome pupil, he gave him a sound
whipping.
There was some ground for the general protest that arose from the
high school. Ted was a favorite with every one. The crude principal
had struck one but he had wounded all. His untactfulness had made
him abhorrent to all, even to those who had not hitherto drawn upon
themselves his specific disapproval and useless punishments. Mr.
Bradley, perhaps, never knew that he had undermined his own
usefulness as much by this treatment of a school favorite as by any
single deed that transpired during his whole stay in Newcastle.
He had his own method of handling the problem of whispering. He
made it a rule that every pupil in high school must answer at roll call
at the end of the day on the matter of whispering. If a pupil had
whispered he must answer “Present,” and specify the number of
times during the day he had whispered. If he had a clear record on